Announcement for subsidiary Excelsior Medical (HK) Co., Ltd. regarding the organizational restructuring and share exchange of its investee, Asia Best Healthcare. Co., Ltd.

 

SEQ_NO  3 Date of announcement  2022/10/27 Time of announcement 18:43:26
Subject
Announcement for subsidiary Excelsior Medical (HK) Co.,
Ltd. regarding the organizational restructuring and share
exchange of its investee, Asia Best Healthcare. Co., Ltd.
Date of events 2022/10/27 To which item it meets paragraph 20
Statement
1.Name and nature of the underlying assets (if preferred 
  shares, the terms and conditions of issuance shall also 
  be indicated, e.g., dividend yield,etc.):
 1.Asia Best Healthcare Co.,Ltd. shall repurchase its own
   common shares from Excelsior Medical (HK) Co., Limited.
 2.Excelsior Medical (HK) Co., Limited. shall acquire 
   common shares of ASIA BEST LIFE CARE TECHNOLOGY CO., 
   LTD.( the subsidiary of Asia Best Healthcare Co.,Ltd.)
   for consideration.
2.Date of occurrence of the event:2022/10/27
3.Amount, unit price, and total monetary amount of the 
  transaction:
 1. Based on the net worth in 2022/05/31 financial report 
    of Asia Best Healthcare Co.,Ltd., Asia Best Healthcare
    Co.,Ltd. repurchases its own 1 share from the original
    shareholders and exchanges its subsidiary ASIA BEST 
    LIFE CARE TECHNOLOGY CO., LTD. common stock 404.35 
    shares.
 2.Asia Best Healthcare Co.,Ltd. buybacks its own common 
   shares 209,308 shares from Excelsior Medical (HK) Co., 
   Limited. and Excelsior Medical (HK) Co.,Limited. 
   acquires common shares 84,633,340 shares of ASIA BEST
   LIFE CARE TECHNOLOGY CO., LTD. for consideration.
 3.Based on the 2022/05/31 financial report of Asia Best 
   Healthcare Co.,Ltd.,the per share net worth of ASIA 
   BEST LIFE CARE TECHNOLOGY CO., LTD. is NTD 10.2954, 
   the amount of the total shares of ASIA BEST LIFE CARE
   TECHNOLOGY CO.,LTD.acquired by Excelsior Medical (HK)
   Co., Limited.is NTD871,334 thousands.
4.Trading counterparty and its relationship with the
  Company (if the trading counterparty is a natural 
  person and furthermore is not a related party of the 
  Company, the name of the trading counterparty is not
  required to be disclosed):
  Both Asia Best Healthcare Co.,Ltd.and ASIA BEST LIFE 
  CARE TECHNOLOGY CO., LTD. are the related party of the
  company.
5.Where the trading counterparty is a related party, 
  announcement shall also be made of the reason for 
  choosing the related party as trading counterparty
  and the identity of the previous owner, its 
  relationship with the Company and the trading 
  counterparty, and the previous date and monetary amount 
  of transfer:
  Asia Best Healthcare Co.,Ltd. reorganizes the 
  organizational structure. The identity of the previous
  owner, its relationship with the Company and the trading
  counterparty, and the previous date and monetary amount 
  of transfer: Not Applicable.
6.Where an owner of the underlying assets within the past
  five years has been a related party of the Company, the 
  announcement shall also include the date and price of
  acquisition and disposal by the related party, and its
  relationship with the Company at the time of the 
  transaction:Not Applicable.
7.Matters related to the current disposal of creditors'
  rights (including types of collaterals of the disposed
  creditor’s rights; if creditor's rights over a related 
  party, announcement shall be made of the name of the
  related party and the book amount of the creditor's 
  rights, currently being disposed of, over such related 
  party):Not Applicable.
8.Profit or loss from the disposal (not applicable in 
  cases of acquisition of securities) (those with 
  deferral should provide a table explaining recognition):
  Not Applicable.
9.Terms of delivery or payment (including payment period 
  and monetary amount), restrictive covenants in the 
  contract, and other important terms and conditions:
  Terms of delivery or payment: Not Applicable.
  Conditions precedent to closing:
  Asia Best Healthcare Co.,Ltd. will reduce its share 
  capital after completion of statutory procedures, 
  Excelsior Medical (HK) Co., Limited. will acquire
  common shares of ASIA BEST LIFE CARE TECHNOLOGY CO., 
  LTD.
  The unit price, and total monetary amount of the 
  transaction will be changed on the settlement date.
10.The manner of deciding on this transaction (such as
   invitation to tender, price comparison, or price 
   negotiation), the reference basis for the decision 
   on price, and the decision-making unit:
   The manner of deciding on this transaction: To be 
   decided by Asia Best Healthcare Co.,Ltd.'s 
   sharesholders'meeting resolution. 
   The reference basis for the decision on price: 
   Opinion on the reasonablesness of the Share Exchange
   ratio issued by Integritas CPA Firm.
   The decision-making department:Asia Best Healthcare 
   Co.,Ltd.'s sharesholders'meeting.
11.Net worth per share of the Company's underlying 
   securities acquired or disposed of:Not Applicable.
12.Cumulative no.of shares held (including the current
   transaction), their monetary amount, shareholding 
   percentage, and status of any restriction of rights
   (e.g., pledges), as of the present moment:
   Cumulative no. of shares held:
   Asia Best Healthcare Co.,Ltd.:129,492 common shares.
   ASIA BEST LIFE CARE TECHNOLOGY CO.,LTD.:84,633,340 
   common shares.
   Cumulative monetary amount:
   Asia Best Healthcare Co.,Ltd.:USD19,484,706.
   ASIA BEST LIFE CARE TECHNOLOGY CO.,LTD.:USD32,110,038.
   Shareholding percentage:
   The final figure depends on the willingness of Asia 
   Best Healthcare Co.,Ltd.'s original shareholders for
   share exchange.
   restriction of rights: None.
13.Current ratio of securities investment (including the
   current trade, as listed in article 3 of Regulations
   Governing the Acquisition and Disposal of Assets by
   Public Companies) to the total assets and equity
   attributable to owners of the parent as shown in the
   most recent financial statement and working capital as
   shown in the most recent financial statement as of the
   present:
   Ratio to total assets:28.78%
   Ratio to shareholders'equity of the parent company: 
   33.43%
   Amount of working capital::NTD 1,150,828 thousands.
14.Broker and broker's fee:Not Applicable.
15.Concrete purpose or use of the acquisition or disposal:
   The organizational restructuring of Asia Best 
   Healthcare Co.,Ltd.
16.Any dissenting opinions of directors to the present 
   transaction:NO.
17.Whether the counterparty of the current transaction 
   is a related party:YES.
18.Date of the board of directors resolution:2022/10/27
19.Date of ratification by supervisors or approval by the 
   Audit Committee:NA
20.Whether the CPA issued an unreasonable opinion 
   regarding the current transaction:Not Applicable.
21.Name of the CPA firm:Integritas CPA Firm.
22.Name of the CPA:Wu-Hung-Yi
23.Practice certificate number of the CPA:
   CPA Associations R.O.C.(Taiwan) No.1070015
24.Whether the transaction involved in change of business 
   model:NO.
25.Details on change of business model:Not Applicable.
26.Details on transactions with the counterparty for the 
   past year and the expected coming year:Not Applicable.
27.Source of funds:Not Applicable.
28.Any other matters that need to be specified:None.